Exercise program for cancer patients at risk of heart issues

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the outcomes of a Cardio-Oncology Rehabilitation (CORe) program that focuses on exercise for cancer patients undergoing treatments that may cause heart problems. Participants will be offered either in-person or remote exercise options based on their functional assessments and preferences. The program includes a 3-month supervised exercise intervention, with health indicators, functional capacity, and quality of life assessed at baseline, after the intervention, and at a 9-month follow-up. The goal is to improve the overall treatment experience and quality of life for patients at risk of cardiotoxicity.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* High risk of cancer treatment-related cardiotoxicity
* Possibility of completing a cardio-onco rehabilitation program (centre-based or home-based) and programmed visits.
* Providing written informed consent.

Exclusion Criteria:

* Patients with physical or mental limitation to carry out an exercise program.

Where it's running

• Hospital Clínico Universitario de Santiago
  Santiago de Compostela, A Coruña, Spain Recruiting

Study contacts

• Study coordinator: Estíbaliz Díaz-Balboa, PT
• Email: estibaliz.diaz.balboa@sergas.es
• Phone: +34 981950747

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• One-stop photon-counting CT for patients after PCI

  This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07763340

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.